Proserpio, Paola http://orcid.org/0000-0002-2905-3996
Biggio, Giovanni
Ferri, Raffaele
Girardi, Paolo
Agostoni, Elio Clemente
Manni, Raffaele
Minervino, Antonino
Palagini, Laura
Plazzi, Giuseppe
Nobili, Lino
Arnaldi, Dario
Article History
Received: 5 April 2022
Accepted: 28 July 2022
First Online: 4 August 2022
Declarations
:
: The study was approved by the Ethical Committee “Comitato Etico Regionale della Liguria” (Register Number: 143/2022_ DB id 12,253).
: Paola Proserpio has received honoraria for advisory board from Italfarmaco and Jazz Pharmaceuticals. Raffaele Ferri has received consulting fee from Jazz Pharmaceutical. Raffaele Manni has received consulting fee from Fidia Pharma. Giuseppe Plazzi has received consulting fees from Jazz Pharmaceuticals, Takeda, Idorsia, and Bioprojet. Dario Arnaldi has received honoraria for lectures from Bruno Pharma, Fidia Pharma, and Jazz Pharmaceuticals. Lino Nobili has received honoraria for lectures from Bioprojet and consulting fees from Fidia Pharma, Eisai, and Roche. All other authors have no relevant conflict of interests to disclose related to the content of the current manuscript.
Free to read: This content has been made available to all.